{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:40:01Z","timestamp":1745307601089,"version":"3.40.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00520-025-09344-6","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T06:34:41Z","timestamp":1743402881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preventing chemotherapy-induced ovarian damage through PI3K\/AKT and Hippo pathway regulation"],"prefix":"10.1007","volume":"33","author":[{"given":"Negin","family":"Zatalian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Dalman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Gourabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"9344_CR1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/13697137.2019.1607285","volume":"22","author":"S Hunt","year":"2019","unstructured":"Hunt S, Vollenhoven B (2019) Fertility preservation in women with cancer and afterward. Climacteric 22:579\u2013583","journal-title":"Climacteric"},{"key":"9344_CR2","first-page":"2607","volume":"41","author":"S Del-Pozo-L\u00e9rida","year":"2019","unstructured":"Del-Pozo-L\u00e9rida S, Salvador C, Mart\u00ednez-Soler F, Tortosa A, Perucho M, Gim\u00e9nez-Bonaf\u00e9 P (2019) Preservation of fertility in patients with cancer. Oncol Rep 41:2607\u20132614","journal-title":"Oncol Rep"},{"key":"9344_CR3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","volume":"25","author":"N Spears","year":"2019","unstructured":"Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson R, Klinger F (2019) Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update 25:673\u2013693","journal-title":"Hum Reprod Update"},{"doi-asserted-by":"publisher","unstructured":"Cacciottola L, Donnez J, Dolmans M-MJBP, Obstetrics RC, Gynaecology (2022) Ovarian tissue and oocyte cryopreservation prior to iatrogenic premature ovarian insufficiency 81: 119-133.\u00a0https:\/\/doi.org\/10.1016\/j.bpobgyn.2021.09.010","key":"9344_CR4","DOI":"10.1016\/j.bpobgyn.2021.09.010"},{"key":"9344_CR5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.reprotox.2008.09.014","volume":"26","author":"Z Barekati","year":"2008","unstructured":"Barekati Z, Gourabi H, Yazdi PE (2008) Previous maternal chemotherapy by cyclophosphamide (Cp) causes numerical chromosome abnormalities in preimplantation mouse embryos. Reprod Toxicol 26:278\u2013281","journal-title":"Reprod Toxicol"},{"key":"9344_CR6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/1933719111426599","volume":"19","author":"Z Barekati","year":"2012","unstructured":"Barekati Z, Golkar-Narenji A, Totonchi M, Radpour R, Gourabi H (2012) Effects of amifostine in combination with cyclophosphamide on female reproductive system. Reprod Sci 19:539\u2013546","journal-title":"Reprod Sci"},{"key":"9344_CR7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10815-013-0035-9","volume":"30","author":"A Golkar-Narenji","year":"2013","unstructured":"Golkar-Narenji A, Barekati Z, Eimani H, Shabani F, Gourabi H (2013) The influence of amifostine administration prior to cyclophosphamide on in vitro maturation of mouse oocytes. J Assist Reprod Genet 30:939\u2013944","journal-title":"J Assist Reprod Genet"},{"key":"9344_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-319-31973-5_7","volume-title":"Ovarian folliculogenesisMolecular mechanisms of cell differentiation in gonad development","author":"N Rimon-Dahari","year":"2016","unstructured":"Rimon-Dahari N, Yerushalmi-Heinemann L, Alyagor L, Dekel N (2016) Ovarian folliculogenesisMolecular mechanisms of cell differentiation in gonad development. Springer, Cham, pp 167\u2013190"},{"key":"9344_CR9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.fertnstert.2020.08.010","volume":"114","author":"J Donnez","year":"2020","unstructured":"Donnez J (2020) Chemotherapy and decline of the ovarian reserve: how can we explain it and how to prevent it? Fertil Steril 114:722\u2013724","journal-title":"Fertil Steril"},{"doi-asserted-by":"publisher","unstructured":"Zhou Y, Richard S, Batchelor N, Oorschot D, Anderson G, Pankhurst MJHR (2022) Anti-M\u00fcllerian hormone-mediated preantral follicle atresia is a key determinant of antral follicle count in mice 37: 2635-2645.\u00a0https:\/\/doi.org\/10.1093\/humrep\/deac204","key":"9344_CR10","DOI":"10.1093\/humrep\/deac204"},{"doi-asserted-by":"publisher","unstructured":"Cedars MIJTJoCE, Metabolism (2022) Evaluation of female fertility\u2014AMH and ovarian reserve testing 107: 1510\u20131519.\u00a0https:\/\/doi.org\/10.1210\/clinem\/dgac039","key":"9344_CR11","DOI":"10.1210\/clinem\/dgac039"},{"doi-asserted-by":"publisher","unstructured":"Bedenk J, Vrta\u010dnik-Bokal E, Virant-Klun IJJoar, genetics (2020) The role of anti-M\u00fcllerian hormone (AMH) in ovarian disease and infertility 37: 89\u2013100.\u00a0https:\/\/doi.org\/10.1007\/s10815-019-01622-7a","key":"9344_CR12","DOI":"10.1007\/s10815-019-01622-7a"},{"doi-asserted-by":"publisher","unstructured":"Maidarti M, Anderson RA, Telfer EE (2020) Crosstalk between PTEN\/PI3K\/Akt signalling and DNA damage in the oocyte: implications for primordial follicle activation, oocyte quality and ageing Cells 9: 200.\u00a0https:\/\/doi.org\/10.3390\/cells9010200","key":"9344_CR13","DOI":"10.3390\/cells9010200"},{"doi-asserted-by":"publisher","unstructured":"Calses PC, Crawford JJ, Lill JR, Dey A (2019) Hippo pathway in cancer: aberrant regulation and therapeutic opportunities Trends in cancer 5: 297-307.\u00a0https:\/\/doi.org\/10.1016\/j.trecan.2019.04.001","key":"9344_CR14","DOI":"10.1016\/j.trecan.2019.04.001"},{"doi-asserted-by":"publisher","unstructured":"Meng Z, Moroishi T, Guan K-LJG, development (2016) Mechanisms of Hippo pathway regulation 30: 1-17.\u00a0https:\/\/doi.org\/10.1101\/gad.274027.115","key":"9344_CR15","DOI":"10.1101\/gad.274027.115"},{"key":"9344_CR16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1159\/000369752","volume":"35","author":"C Xiang","year":"2015","unstructured":"Xiang C, Li J, Hu L, Huang J, Luo T, Zhong Z, Zheng Y, Zheng L (2015) Hippo signaling pathway reveals a spatio-temporal correlation with the size of primordial follicle pool in mice. Cell Physiol Biochem 35:957\u2013968","journal-title":"Cell Physiol Biochem"},{"key":"9344_CR17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.fertnstert.2020.07.031","volume":"114","author":"AJ Hsueh","year":"2020","unstructured":"Hsueh AJ, Kawamura K (2020) Hippo signaling disruption and ovarian follicle activation in infertile patients. Fertil Steril 114:458\u2013464","journal-title":"Fertil Steril"},{"key":"9344_CR18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/biolre\/ioz215","volume":"102","author":"M Devos","year":"2020","unstructured":"Devos M, Grosbois J, Demeestere I (2020) Interaction between PI3K\/AKT and Hippo pathways during in vitro follicular activation and response to fragmentation and chemotherapy exposure using a mouse immature ovary model. Biol Reprod 102:717\u2013729","journal-title":"Biol Reprod"},{"key":"9344_CR19","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/jcp.27024","volume":"234","author":"LL Hu","year":"2019","unstructured":"Hu LL, Su T, Luo RC, Zheng YH, Huang J, Zhong ZS, Nie J, Zheng LP (2019) Hippo pathway functions as a downstream effector of AKT signaling to regulate the activation of primordial follicles in mice. J Cell Physiol 234:1578\u20131587","journal-title":"J Cell Physiol"},{"key":"9344_CR20","doi-asserted-by":"crossref","first-page":"17474","DOI":"10.1073\/pnas.1312830110","volume":"110","author":"K Kawamura","year":"2013","unstructured":"Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, Ho C-h, Kawamura N, Tamura M, Hashimoto S (2013) Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proceed Nat Acad Sci 110:17474\u201317479","journal-title":"Proceed Nat Acad Sci"},{"key":"9344_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0664-4","volume":"37","author":"W Xu","year":"2018","unstructured":"Xu W, Yang Z, Xie C, Zhu Y, Shu X, Zhang Z, Li N, Chai N, Zhang S, Wu K (2018) PTEN lipid phosphatase inactivation links the hippo and PI3K\/Akt pathways to induce gastric tumorigenesis. J Exp Clin Cancer Res 37:1\u201316","journal-title":"J Exp Clin Cancer Res"},{"key":"9344_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00592-020-01582-w","volume":"58","author":"X Qian","year":"2021","unstructured":"Qian X, He L, Hao M, Li Y, Li X, Liu Y, Jiang H, Xu L, Li C, Wu W (2021) YAP mediates the interaction between the Hippo and PI3K\/Akt pathways in mesangial cell proliferation in diabetic nephropathy. Acta Diabetologica 58:47\u201362","journal-title":"Acta Diabetologica"},{"doi-asserted-by":"publisher","unstructured":"Sonigo C, Beau I, Binart N, Grynberg M (2022) Medical treatments for ovarian protectionFemale and Male Fertility Preservation. Springer 341\u2013352.\u00a0https:\/\/doi.org\/10.1007\/978-3-030-47767-7_27","key":"9344_CR23","DOI":"10.1007\/978-3-030-47767-7_27"},{"key":"9344_CR24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/molehr\/gaaa043","volume":"26","author":"KJ Szymanska","year":"2020","unstructured":"Szymanska KJ, Tan X, Oktay K (2020) Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging. Mol Human Reprod 26:553\u2013566","journal-title":"Mol Human Reprod"},{"key":"9344_CR25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1096\/fj.201801089R","volume":"33","author":"C Sonigo","year":"2019","unstructured":"Sonigo C, Beau I, Grynberg M, Binart N (2019) AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J 33:1278\u20131287","journal-title":"FASEB J"},{"key":"9344_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.18632\/aging.101376","volume":"10","author":"Y-C Sun","year":"2018","unstructured":"Sun Y-C, Wang Y-Y, Sun X-F, Cheng S-F, Li L, Zhao Y, Shen W, Chen H (2018) The role of autophagy during murine primordial follicle assembly. Aging (Albany NY) 10:197","journal-title":"Aging (Albany NY)"},{"key":"9344_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","volume":"40","author":"F Ardito","year":"2017","unstructured":"Ardito F, Giuliani M, Perrone D, Troiano G, Lo Muzio L (2017) The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy. Int J Mol Med 40:271\u2013280","journal-title":"Int J Mol Med"},{"key":"9344_CR28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, Li W, Hu J, Lu C, Liu Y (2020) PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Disease 11:797","journal-title":"Cell Death Disease"},{"doi-asserted-by":"publisher","unstructured":"Fu M, Hu Y, Lan T, Guan K-L, Luo T, Luo MJSt, therapy t (2022) The Hippo signalling pathway and its implications in human health and diseases 7:376.\u00a0https:\/\/doi.org\/10.1038\/s41392-022-01191-9","key":"9344_CR29","DOI":"10.1038\/s41392-022-01191-9"},{"doi-asserted-by":"publisher","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li BJSt, therapy t (2021) Targeting PI3K\/Akt signal transduction for cancer therapy 6:425.\u00a0https:\/\/doi.org\/10.1038\/s41392-021-00828-5","key":"9344_CR30","DOI":"10.1038\/s41392-021-00828-5"},{"key":"9344_CR31","doi-asserted-by":"crossref","first-page":"E3729","DOI":"10.1073\/pnas.1703096114","volume":"114","author":"TS Gujral","year":"2017","unstructured":"Gujral TS, Kirschner MW (2017) Hippo pathway mediates resistance to cytotoxic drugs. Proc Natl Acad Sci 114:E3729\u2013E3738","journal-title":"Proc Natl Acad Sci"},{"key":"9344_CR32","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/ijc.29293","volume":"137","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Yang X (2015) The Hippo pathway in chemotherapeutic drug resistance. Int J Cancer 137:2767\u20132773","journal-title":"Int J Cancer"},{"doi-asserted-by":"publisher","unstructured":"Di Emidio G, Rossi G, Bonomo I, Alonso GL, Sferra R, Vetuschi A, Artini PG, Provenzani A, Falone S, Carta G (2017) The natural carotenoid crocetin and the synthetic tellurium compound AS101 protect the ovary against cyclophosphamide by modulating SIRT1 and mitochondrial markers. Oxid Med Cell Longev 2017.\u00a0https:\/\/doi.org\/10.1155\/2017\/8928604","key":"9344_CR33","DOI":"10.1155\/2017\/8928604"},{"key":"9344_CR34","doi-asserted-by":"crossref","first-page":"185ra162","DOI":"10.1126\/scitranslmed.3005402","volume":"5","author":"L Kalich-Philosoph","year":"2013","unstructured":"Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, Wolf I, Kanety H, Sredni B, Meirow D (2013) Cyclophosphamide triggers follicle activation and \u201cburnout\u201d; AS101 prevents follicle loss and preserves fertility. Sci Translat Med 5:185ra162-185ra162","journal-title":"Sci Translat Med"},{"key":"9344_CR35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.theriogenology.2023.05.023","volume":"207","author":"Z Dong","year":"2023","unstructured":"Dong Z, Zhang L, Wang W, Jiang F, Ai H (2023) ZnSO4 protects against premature ovarian failure through PI3K\/AKT\/GSK3\u03b2 signaling pathway. Theriogenology 207:61\u201371","journal-title":"Theriogenology"},{"key":"9344_CR36","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s43032-021-00768-z","volume":"29","author":"RS Barberino","year":"2022","unstructured":"Barberino RS, Lins TLB, Monte AP, Gouveia BB, Campinho DS, Palheta RC, Smitz JE, Matos MHT (2022) Melatonin attenuates cyclophosphamide-induced primordial follicle loss by interaction with MT1 receptor and modulation of PTEN\/Akt\/FOXO3a proteins in the mouse ovary. Reprod Sci 29:2505\u20132514","journal-title":"Reprod Sci"},{"doi-asserted-by":"publisher","unstructured":"Feng J, Ma W-W, Li H-X, Pei X-Y, Deng S-L, Jia H, Ma W-Z (2022) Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression. Front Endocrinol 13.\u00a0https:\/\/doi.org\/10.3389\/fendo.2022.895095","key":"9344_CR37","DOI":"10.3389\/fendo.2022.895095"},{"key":"9344_CR38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jpi.12316","volume":"60","author":"H Jang","year":"2016","unstructured":"Jang H, Lee OH, Lee Y, Yoon H, Chang EM, Park M, Lee JW, Hong K, Kim JO, Kim NK (2016) Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN\/AKT\/FOXO 3a pathway activation in the mouse ovary. J Pineal Res 60:336\u2013347","journal-title":"J Pineal Res"},{"key":"9344_CR39","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/pharmaceutics14122769","volume":"14","author":"A Al-Shahat","year":"2022","unstructured":"Al-Shahat A, Hulail MA, Soliman NM, Khamis T, Fericean LM, Arisha AH, Moawad RS (2022) Melatonin mitigates cisplatin-induced ovarian dysfunction via altering steroidogenesis, inflammation, apoptosis, oxidative stress, and PTEN\/PI3K\/Akt\/mTOR\/AMPK signaling pathway in female rats. Pharmaceutics 14:2769","journal-title":"Pharmaceutics"},{"doi-asserted-by":"publisher","unstructured":"Sevgin K, Erguven PJB, Communications BR (2024) SIRT1 overexpression by melatonin and resveratrol combined treatment attenuates premature ovarian failure through activation of SIRT1\/FOXO3a\/BCL2 pathway 696: 149506.\u00a0https:\/\/doi.org\/10.1016\/j.bbrc.2024.149506","key":"9344_CR40","DOI":"10.1016\/j.bbrc.2024.149506"},{"key":"9344_CR41","first-page":"096032712211274","volume":"41","author":"H Xu","year":"2022","unstructured":"Xu H, Bao X, Kong H, Yang J, Li Y, Sun Z (2022) Melatonin protects against cyclophosphamide-induced premature ovarian failure in rats. Hum Exp Toxicol 41:09603271221127430","journal-title":"Hum Exp Toxicol"},{"key":"9344_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-016-0301-4","volume":"10","author":"L Zhou","year":"2017","unstructured":"Zhou L, Xie Y, Li S, Liang Y, Qiu Q, Lin H, Zhang Q (2017) Rapamycin prevents cyclophosphamide-induced over-activation of primordial follicle pool through PI3K\/Akt\/mTOR signaling pathway in vivo. J Ovar Res 10:1\u201311","journal-title":"J Ovar Res"},{"key":"9344_CR43","doi-asserted-by":"crossref","first-page":"gaaa084","DOI":"10.1093\/molehr\/gaaa084","volume":"27","author":"C-C Huang","year":"2021","unstructured":"Huang C-C, Chou C-H, Yang Y-S, Ho H-N, Shun C-T, Wen W-F, Chen S-U, Chen M-J (2021) Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy. Mol Human Reprod 27:gaaa084","journal-title":"Mol Human Reprod"},{"key":"9344_CR44","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/mrd.23330","volume":"87","author":"Y Xie","year":"2020","unstructured":"Xie Y, Li S, Zhou L, Lin H, Jiao X, Qiu Q, Liang Y, Zhang Q (2020) Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo. Mol Reprod Dev 87:442\u2013453","journal-title":"Mol Reprod Dev"},{"doi-asserted-by":"publisher","unstructured":"Rosario R, Stewart HL, Spears N, Telfer EE, Anderson RAJHR (2024) Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro 39: 382\u2013392.\u00a0https:\/\/doi.org\/10.1093\/humrep\/dead255","key":"9344_CR45","DOI":"10.1093\/humrep\/dead255"},{"doi-asserted-by":"publisher","unstructured":"Tanaka Y, Amano T, Nakamura A, Yoshino F, Takebayashi A, Takahashi A, Yamanaka H, Inatomi A, Hanada T, Yoneoka YJHR (2024) Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model: deae085.\u00a0https:\/\/doi.org\/10.1093\/humrep\/deae085","key":"9344_CR46","DOI":"10.1093\/humrep\/deae085"},{"key":"9344_CR47","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/humrep\/dead064","volume":"38","author":"O Kashi","year":"2023","unstructured":"Kashi O, Roness H, Spector I, Derech-Haim S, Meirow D (2023) Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve. Hum Reprod 38:1086\u20131098","journal-title":"Hum Reprod"},{"key":"9344_CR48","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.3390\/ijms20246311","volume":"20","author":"S Wang","year":"2019","unstructured":"Wang S, Lin S, Zhu M, Li C, Chen S, Pu L, Lin J, Cao L, Zhang Y (2019) Acupuncture reduces apoptosis of granulosa cells in rats with premature ovarian failure via restoring the PI3K\/Akt signaling pathway. Int J Mol Sci 20:6311","journal-title":"Int J Mol Sci"},{"key":"9344_CR49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/bcpt.13696","volume":"130","author":"S Zheng","year":"2022","unstructured":"Zheng S, Ma M, Chen Y, Li M (2022) Effects of quercetin on ovarian function and regulation of the ovarian PI3K\/Akt\/FoxO3a signalling pathway and oxidative stress in a rat model of cyclophosphamide-induced premature ovarian failure. Basic Clin Pharmacol Toxicol 130:240\u2013253","journal-title":"Basic Clin Pharmacol Toxicol"},{"doi-asserted-by":"publisher","unstructured":"Zatalian N, Dalman A, Afsharian P, Hezavehei M, Gourabi HJJoOR (2024) Metformin protects prepubertal mice ovarian reserve against cyclophosphamide via regulation of the PI3K\/Akt\/mTOR signaling pathway and Yap-1 17: 251.\u00a0https:\/\/doi.org\/10.1186\/s13048-024-01572-4","key":"9344_CR50","DOI":"10.1186\/s13048-024-01572-4"},{"key":"9344_CR51","doi-asserted-by":"crossref","first-page":"711902","DOI":"10.3389\/fendo.2021.711902","volume":"12","author":"Z Li","year":"2021","unstructured":"Li Z, Zhang M, Zheng J, Tian Y, Zhang H, Tan Y, Li Q, Zhang J, Huang X (2021) Human umbilical cord mesenchymal stem cell-derived exosomes improve ovarian function and proliferation of premature ovarian insufficiency by regulating the hippo signaling pathway. Front Endocrinol 12:711902","journal-title":"Front Endocrinol"},{"doi-asserted-by":"publisher","unstructured":"Liu W, Chen Q, Liu Z, Weng Z, Nguyen TN, Feng J, Zhou S (2021) Zihuai recipe alleviates cyclophosphamide-induced diminished ovarian reserve via suppressing PI3K\/AKT-mediated apoptosis. J Ethnopharmacol 277:113789.\u00a0https:\/\/doi.org\/10.1016\/j.jep.2021.113789","key":"9344_CR52","DOI":"10.1016\/j.jep.2021.113789"},{"key":"9344_CR53","doi-asserted-by":"crossref","first-page":"115842","DOI":"10.1016\/j.jep.2022.115842","volume":"301","author":"X Liu","year":"2023","unstructured":"Liu X, Song Y, Zhou F, Zhang C, Li F, Hu R, Ma W, Song K, Tang Z, Zhang M (2023) Network and experimental pharmacology on mechanism of Si-Wu-tang improving ovarian function in a mouse model of premature ovarian failure induced by cyclophosphamide. J Ethnopharmacol 301:115842","journal-title":"J Ethnopharmacol"},{"doi-asserted-by":"publisher","unstructured":"Liu H, Yang H, Qin Z, Chen Y, Yu H, Li W, Zhu X, Cai J, Chen J, Zhang M (2021) Exploration of the Danggui Buxue decoction mechanism regulating the balance of ESR and AR in the TP53-AKT signaling pathway in the prevention and treatment of POF. Evid-Based Complement Alternat Med 2021.\u00a0https:\/\/doi.org\/10.1155\/2021\/4862164","key":"9344_CR54","DOI":"10.1155\/2021\/4862164"},{"key":"9344_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-020-00681-1","volume":"19","author":"J Li","year":"2021","unstructured":"Li J, Long H, Cong Y, Gao H, Lyu Q, Yu S, Kuang Y (2021) Quercetin prevents primordial follicle loss via suppression of PI3K\/Akt\/Foxo3a pathway activation in cyclophosphamide-treated mice. Reprod Biol Endocrinol 19:1\u201311","journal-title":"Reprod Biol Endocrinol"},{"key":"9344_CR56","doi-asserted-by":"crossref","first-page":"153752","DOI":"10.1016\/j.phymed.2021.153752","volume":"92","author":"Q Chen","year":"2021","unstructured":"Chen Q, Xu Z, Li X, Du D, Wu T, Zhou S, Yan W, Wu M, Jin Y, Zhang J (2021) Epigallocatechin gallate and theaflavins independently alleviate cyclophosphamide-induced ovarian damage by inhibiting the overactivation of primordial follicles and follicular atresia. Phytomedicine 92:153752","journal-title":"Phytomedicine"},{"key":"9344_CR57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.reprotox.2022.08.010","volume":"113","author":"RS Barberino","year":"2022","unstructured":"Barberino RS, Lins TLB, Monte AP, Silva RLS, Andrade KO, Campinho DS, Junior RCP, Smitz JE, Matos MHT (2022) Epigallocatechin-3-gallate attenuates cyclophosphamide-induced damage in mouse ovarian tissue via suppressing inflammation, apoptosis, and expression of phosphorylated Akt, FOXO3a and rpS6. Reprod Toxicol 113:42\u201351","journal-title":"Reprod Toxicol"},{"key":"9344_CR58","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s43032-020-00305-4","volume":"28","author":"BB Gouveia","year":"2021","unstructured":"Gouveia BB, Barberino RdS, dos Santos Silva RL, Lins TLBG, da Silva Guimar\u00e3es V, do Monte APO, Palheta RC, de Matos MHT, (2021) Involvement of PTEN and FOXO3a proteins in the protective activity of protocatechuic acid against cisplatin-induced ovarian toxicity in mice. Reprod Sci 28:865\u2013876","journal-title":"Reprod Sci"},{"doi-asserted-by":"publisher","unstructured":"Tao H, Chen Z, Yao B, Ren X, Shuai H, Xu S, Zha Q, Li PJBc (2024) Galaxamide alleviates cisplatin-induced premature ovarian insufficiency via the PI3K signaling pathway in HeLa tumor-bearing mice 24: 1\u201310.\u00a0https:\/\/doi.org\/10.1186\/s12885-024-12848-9","key":"9344_CR59","DOI":"10.1186\/s12885-024-12848-9"},{"key":"9344_CR60","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s00210-024-03395-y","volume":"398","author":"BG Eid","year":"2025","unstructured":"Eid BG, Binmahfouz LS, Shaik RA, Bagher AM, Sirwi A, Abdel-Naim ABJN-SsAoP (2025) Icariin inhibits cisplatininduced\u00a0ovarian toxicity via modulating NF-\u03baB and PTEN\/AKT\/mTOR\/AMPK axis. 398:1949\u20131959. https:\/\/doi.org\/10.1007\/s00210-024-03395-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"doi-asserted-by":"publisher","unstructured":"Su C, Zhang R, Zhang X, Lv M, Liu X, Ao K, Hao J, Mu Y-l (2023) Dingkun Pill modulate ovarian function in chemotherapy-induced premature ovarian insufficiency mice by regulating PTEN\/PI3K\/AKT\/FOXO3a signaling pathway. J Ethnopharmacol 116703.\u00a0https:\/\/doi.org\/10.1016\/j.jep.2023.116703","key":"9344_CR61","DOI":"10.1016\/j.jep.2023.116703"},{"key":"9344_CR62","doi-asserted-by":"crossref","first-page":"116608","DOI":"10.1016\/j.jep.2023.116608","volume":"314","author":"Z Xiu","year":"2023","unstructured":"Xiu Z, Tang S, Kong P, Yan M, Tong X, Liu X, Liang X, Li R, Duan Y (2023) Zigui-Yichong-Fang protects against cyclophosphamide-induced premature ovarian insufficiency via the SIRT1\/Foxo3a pathway. J Ethnopharmacol 314:116608","journal-title":"J Ethnopharmacol"},{"key":"9344_CR63","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/jmcb\/mjz105","volume":"12","author":"L Hong","year":"2020","unstructured":"Hong L, Yan L, Xin Z, Hao J, Liu W, Wang S, Liao S, Wang H, Yang X (2020) Protective effects of human umbilical cord mesenchymal stem cell-derived conditioned medium on ovarian damage. J Mol Cell Biol 12:372\u2013385","journal-title":"J Mol Cell Biol"},{"doi-asserted-by":"publisher","unstructured":"Cui M, Liu Y, Men X, Li T, Liu D, Deng YJFiC, Biology D (2023) Large animal models in the study of gynecological diseases 11:1110551.\u00a0https:\/\/doi.org\/10.3389\/fcell.2023.1110551","key":"9344_CR64","DOI":"10.3389\/fcell.2023.1110551"},{"doi-asserted-by":"publisher","unstructured":"Doncheva NT, Palasca O, Yarani R, Litman T, Anthon C, Groenen MA, Stadler PF, Pociot F, Jensen LJ, Gorodkin JJNar (2021) Human pathways in animal models: possibilities and limitations 49: 1859-1871.\u00a0https:\/\/doi.org\/10.1093\/nar\/gkab012","key":"9344_CR65","DOI":"10.1093\/nar\/gkab012"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09344-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09344-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09344-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:10:45Z","timestamp":1745305845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09344-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9344"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09344-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}